Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott LaboratoriesfiledCriticalAbbott Laboratories
Priority to ES0238315ApriorityCriticalpatent/ES238315A1/en
Publication of ES238315A1publicationCriticalpatent/ES238315A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Saccharide Compounds
(AREA)
Abstract
"Method for the manufacture of an erythromycin ester", characterized in that it has the following general formula ** (See formula) ** in which erit is a therapeutically active erythromycin radical, R is a dicarboxylic acid radical and R 'is a radical of an ester group. (Machine-translation by Google Translate, not legally binding)
ES0238315A1957-10-291957-10-29Method for the manufacture of an ester of erythromycin (Machine-translation by Google Translate, not legally binding)
ExpiredES238315A1
(en)
Procedure for the preparation of an insecticide or large composition for use against mosquitoes (Machine-translation by Google Translate, not legally binding)